PCM
QGEN icon

Prelude Capital Management’s Qiagen QGEN Stock Holding History

Prelude Capital Management’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,829
Closed -$101K – 1922
2019
Q4 		$101K Buy
+2,829
New +$105K ﹤0.01% 1096

Other funds holding QGEN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Prelude Capital Management's QGEN Position: Q1 2026 in Review

Prelude Capital Management opened a new position in Qiagen (QGEN) in Q1 2026: 10,124 shares worth $405K. The stake represents 0.03% of the portfolio and ranks #595 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in QGEN as recently as Q3 2022.

Prelude Capital Management first reported a position in QGEN in Q1 2017 and has held it in 11 quarters since. The position peaked at $1.08M in Q2 2022. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Prelude Capital Management held 10,124 shares of Qiagen worth $405K as of Q1 2026.
  • Qiagen was a new Prelude Capital Management position in Q1 2026.
  • Qiagen made up 0.03% of Prelude Capital Management's portfolio in Q1 2026, its #595 holding.
  • Prelude Capital Management first reported a position in Qiagen in Q1 2017 and has held it in 11 quarters since.
  • Prelude Capital Management's Qiagen position peaked at $1.08M in Q2 2022.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.